Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Kiang

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Experimental Hematology & Oncology|January 12, 2025
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancerSharon Pei Yi Chan, Celestia Pei Xuan Yeo, Boon Hao Hong, et al.
Frontiers in Oncology|October 5, 2023
Current management and future challenges in salivary glands cancerLaura D Locati, Renata Ferrarotto, Lisa Licitra, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Prostate cancer management in Southeast Asian countries: a survey of clinical practice patternsEdmund Chiong, Marniza Saad, Agus Rizal A H Hamid, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2022
Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 StudyLei He, Yaxuan Pi, Yi Li, et al.
BMC Cancer|November 14, 2018
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPCKevin Lee Min Chua, Eugenia Li Ling Yeo, Waseem Ahamed Shihabudeen, et al.
Head & Neck|July 8, 2026
Metastatic Count and Local Ablative Therapy Influence Survival Outcomes in Oligometastatic Nasopharyngeal Carcinoma PatientsWanyi Kee, Mei-Kim Ang, Darren Wan-Teck Lim, et al.
Cardio-Oncology (London, England)|March 15, 2022
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational studyYouquan Li, Whee Sze Ong, Ma Than Than Shwe, et al.
The Lancet. Global Health|October 14, 2024
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based studyHongcheng Zhu, Melvin Lee Kiang Chua, Imjai Chitapanarux, et al.
Acta Oncologica (Stockholm, Sweden)|July 14, 2021
A comparative analysis between low-dose-rate brachytherapy and external beam radiation therapy for low- and intermediate-risk prostate cancer in Asian menYouquan Li, Thomas Chan Kong Ngai, Siqin Zhou, et al.
European Thyroid Journal|January 5, 2024
Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid CancerJanice Ser Huey Tan, Timothy Kwang Yong Tay, Enya Hui Wen Ong, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Experimental Hematology & Oncology|January 12, 2025
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancerSharon Pei Yi Chan, Celestia Pei Xuan Yeo, Boon Hao Hong, et al.
Frontiers in Oncology|October 5, 2023
Current management and future challenges in salivary glands cancerLaura D Locati, Renata Ferrarotto, Lisa Licitra, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Prostate cancer management in Southeast Asian countries: a survey of clinical practice patternsEdmund Chiong, Marniza Saad, Agus Rizal A H Hamid, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2022
Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 StudyLei He, Yaxuan Pi, Yi Li, et al.
BMC Cancer|November 14, 2018
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPCKevin Lee Min Chua, Eugenia Li Ling Yeo, Waseem Ahamed Shihabudeen, et al.
Head & Neck|July 8, 2026
Metastatic Count and Local Ablative Therapy Influence Survival Outcomes in Oligometastatic Nasopharyngeal Carcinoma PatientsWanyi Kee, Mei-Kim Ang, Darren Wan-Teck Lim, et al.
Cardio-Oncology (London, England)|March 15, 2022
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational studyYouquan Li, Whee Sze Ong, Ma Than Than Shwe, et al.
The Lancet. Global Health|October 14, 2024
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based studyHongcheng Zhu, Melvin Lee Kiang Chua, Imjai Chitapanarux, et al.
Acta Oncologica (Stockholm, Sweden)|July 14, 2021
A comparative analysis between low-dose-rate brachytherapy and external beam radiation therapy for low- and intermediate-risk prostate cancer in Asian menYouquan Li, Thomas Chan Kong Ngai, Siqin Zhou, et al.
European Thyroid Journal|January 5, 2024
Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid CancerJanice Ser Huey Tan, Timothy Kwang Yong Tay, Enya Hui Wen Ong, et al.
Pageof 6